Fortress Biotech, Inc. (FBIO) — research page
US · us-cm-kg/NASDAQ/FBIO · as of 2026-11-08
Identity and listing
The issuer is Fortress Biotech, Inc., listed on NASDAQ under ticker FBIO, with ISIN US34960Q3074 and LEI 529900DZUWSYUURECK24. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Fortress Biotech, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | FBIO | source · 2026-11-08 |
| ISIN | US34960Q3074 | source · 2026-10-14 |
| LEI | 529900DZUWSYUURECK24 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 40 filings in the twelve months to 2026-11-08, across 23 filing days. The median gap between filing days is 13.0 days. The latest filing is dated 2026-10-29, is of type regulatory_filing, and sits 10 days before the record date. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median latency is 5.0 days, and the NASDAQ median filings count is 52. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, its median latency is 4.0 days, and its median filings count is 63.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 40 | 13 | 10 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-29 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-10-01 | directors_dealings | 4 | 4 |
| 2026-10-01 | corporate_news | 8-K | 8-K — 8-K (items 8.01) |
| 2026-09-01 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-08-13 | results | 10-Q | 10-Q — 10-Q |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names three research houses: Alliance Global Partners, H.C. Wainwright and Global Partners. The count is 3.
| research house | analyst | source · read date |
|---|---|---|
| Alliance Global Partners | Scott Henry | issuer page · 2026-11-11 |
| H.C. Wainwright | Joseph Pantginis | issuer page · 2026-11-11 |
| Global Partners | Joseph Pantginis | issuer page · 2026-11-11 |
Open research
The record holds no openly published research notes; none was found.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001429260.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/FBIO (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://www.fortressbiotech.com/investors/analyst-coverage (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/FBIO (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US34960Q3074"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:da7a5658ece954fa.